Therefore, metabolic abnormalities connected with obesity lead to the development of pathophysiological conditions such as polycystic ovary syndrome and metabolic syndrome, and studies indicate that RSTN may play a role in both diseases [21,22]. This evidence concerns the gene RETN and metabolic syndrome.